Acute flaccid paralysis from mbbs perspective in detail from.ghai book

Reading File

Finding Sources

Reading File

Finding Sources

Reading File

Searching the Web

Ghai Essential Pediatrics acute flaccid paralysis AFP poliomyelitis causes differential diagnosis

Reading File

Reading Web Page

acute flaccid paralysis poliomyelitis GBS causes differential diagnosis treatment children

Now I have enough material from multiple authoritative sources to give a very detailed MBBS-level answer. Let me compile this comprehensively.

Acute Flaccid Paralysis (AFP) - MBBS Level Detail

Note: Ghai's Essential Pediatrics is not available in the textbook library. This answer is compiled from equivalent MBBS-standard sources: Park's PSM, Bradley & Daroff's Neurology, Adams & Victor's Neurology, Goldman-Cecil Medicine, and pediatric AFP teaching material, covering the same content as Ghai.

1. Definition

Acute Flaccid Paralysis (AFP) is defined as the sudden onset of weakness or paralysis (progression within less than 4 weeks) with:

Loss of muscle tone (flaccidity)
Loss of or reduced deep tendon reflexes (hyporeflexia / areflexia)
Occurring in a child under 15 years of age
For which no obvious traumatic cause is identified

AFP is NOT a single diagnosis - it is a clinical syndrome/surveillance case definition, primarily used as a surrogate marker for poliovirus surveillance.

2. AFP as a Surveillance Tool

AFP surveillance is the cornerstone of the Global Polio Eradication Initiative (GPEI). The WHO requires every country to report at least 1 non-polio AFP case per 100,000 children under 15 per year as a minimum sensitivity indicator of the surveillance system.

Four Steps of AFP Surveillance (Park's PSM)

Finding and Reporting - All health facilities (from district health centres to large hospitals) must promptly report every AFP case in children under 15. Active case-finding by public health staff in hospitals and rehabilitation centres.
Stool Sample Collection and Transport - Two stool specimens collected 24-48 hours apart within the first 14 days of onset. Specimens stored at 4-8°C and transported to lab within 72 hours. Poliovirus concentrations are highest in stool during the first 2 weeks after onset.
Poliovirus Isolation - Laboratory virologists isolate and distinguish:
- Wild poliovirus (types 1 and 3; type 2 eradicated since 1999)
- Vaccine-derived poliovirus (VDPV) from OPV
Genetic Mapping - Phylogenetic analysis to pinpoint geographic origin of the virus strain; guides targeted immunization response.

3. Common Causes of AFP in Children

Cause	Key Feature
Poliomyelitis	Asymmetric, fever at onset, residual paralysis at 60 days
Guillain-Barre Syndrome (GBS)	Most common non-polio AFP; ascending, symmetric, post-infectious
Transverse Myelitis	Bilateral, sensory level, bladder/bowel involvement
Traumatic/Injection Neuritis	History of IM injection
Enteroviral AFP (EV-D68, EV-A71, Coxsackie)	Epidemic clusters, may mimic polio
Botulism	Descending paralysis, cranial nerves first
Tick Paralysis	Tick found on body, ascending flaccid paralysis
Acute Disseminated Encephalomyelitis (ADEM)	Post-infectious/post-vaccination, MRI-confirmed
Myasthenia Gravis	Fatigable weakness, ptosis, positive edrophonium test
Periodic Paralysis	Episodic, associated with hypo/hyperkalemia
Spinal cord tumors/compression	Gradual onset, sensory level
Rabies (paralytic form)	Animal bite history, ascending paralysis

4. POLIOMYELITIS (The most important AFP cause in Indian context)

Etiology

Poliovirus: single-stranded RNA enterovirus, family Picornaviridae
3 serotypes: Type 1 (most epidemic paralysis), Type 2 (eradicated 1999), Type 3
Humans are the only natural host

Transmission

Fecal-oral route (primary) - contaminated water/food
Respiratory/oral droplet route (less common)
Incubation period: 5-35 days

Pathogenesis

Virus replicates in nasopharynx and GI tract
Invades lymphoid tissue (tonsils, Peyer's patches)
Viremia → systemic spread
Crosses the blood-brain barrier
Selective destruction of anterior horn cells (motor neurons) in spinal cord and brainstem

Clinical Presentations

A. Inapparent (Subclinical) Infection - ~95% of cases; no symptoms

B. Abortive Poliomyelitis - ~4-8% of cases

Minor illness: fever, sore throat, malaise, nausea, vomiting
Lasts 24-72 hours, complete recovery

C. Non-paralytic Poliomyelitis (Aseptic Meningitis) - ~1-2%

Meningeal signs: neck stiffness, Kernig's/Brudzinski's sign
No paralysis
Self-limiting

D. Paralytic Poliomyelitis - <1% of infected individuals Two-phase illness ("biphasic" or "dromedary back" fever curve):

Minor illness (abortive phase): fever, myalgia, malaise - then apparent recovery
Major illness: re-emergence of fever + rapid onset of asymmetric flaccid weakness

Sub-types:

Spinal type (most common): Lower limb > upper limb involvement; asymmetric; proximal muscles more affected; no sensory loss
Bulbar type: Cranial nerve nuclei involved → dysphagia, dysphonia, respiratory failure; highest mortality (~60%)
Bulbospinal type: Combined spinal + bulbar features; respiratory compromise

Paralysis Characteristics

Asymmetric (key distinguishing feature from GBS)
Flaccid with hypotonia and areflexia
Fever at onset (unlike GBS which is usually afebrile)
No sensory loss
Rapid progression (24-48 hours)
Residual paralysis after 60 days confirms polio

CSF in Poliomyelitis

Cell count: Elevated (10-200 cells), initially PMNs then lymphocytes
Protein: Normal or mildly elevated
Sugar: Normal
Similar to aseptic meningitis

Diagnosis

Stool culture: Gold standard - 2 specimens 24-48 hr apart; positive within first 2 weeks
Throat swab: Less sensitive
CSF: Pleocytosis
Serology: Fourfold rise in antibody titer
Residual paralysis assessment at 60 days (for WHO classification)

Treatment

No specific antiviral therapy
Supportive care:
1. Analgesics for myalgia and headache
2. Mechanical ventilation for bulbar/respiratory paralysis
3. Tracheostomy for long-term ventilatory support
4. Physiotherapy - essential to prevent deformities
5. Orthotic devices as needed
6. Prevention of decubitus ulcers

Prevention

OPV (Oral Polio Vaccine): Live attenuated, 3 serotypes; induces gut immunity; risk of VAPP (~1 in 2.4 million doses)
IPV (Inactivated Polio Vaccine): No VAPP risk; used in developed countries and now added to India's immunization schedule
Pulse Polio Immunization (National Immunization Day): Mass vaccination campaigns in India
AFP surveillance: Mandatory reporting of all AFP cases <15 years

5. GUILLAIN-BARRE SYNDROME (GBS)

Definition

Post-infectious acute polyradiculoneuropathy; the most common cause of AFP globally (more common than polio in the post-vaccine era).

Etiology / Triggering Agents

GBS typically follows an infection by 10-14 days:

Campylobacter jejuni (most common bacterial trigger, ~30%)
Mycoplasma pneumoniae
Hepatitis viruses (A, B, E)
EBV, CMV
COVID-19 (recently identified)
Vaccinations (rarely)

Pathogenesis

Molecular mimicry → autoimmune demyelination of peripheral nerves
Antibodies against gangliosides (GQ1b, GM1) attack myelin or axons

Subtypes

Subtype	Feature
AIDP (Acute Inflammatory Demyelinating Polyneuropathy)	Most common; demyelinating
AMAN (Acute Motor Axonal Neuropathy)	Axonal; common in Asia/China
AMSAN (Acute Motor-Sensory Axonal Neuropathy)	Motor + sensory axonal
Miller-Fisher Syndrome	Ophthalmoplegia + ataxia + areflexia

Clinical Features

Ascending, symmetric flaccid weakness starting in legs, progressing to arms, trunk, and bulbar muscles
Pain and tenderness in limbs (common early symptom - differentiates from polio)
Areflexia (universal)
Sensory symptoms: tingling, paresthesia (mild)
Autonomic dysfunction: blood pressure fluctuation, arrhythmias
Respiratory muscle involvement (30% require ventilation)
No fever at onset
Progression over days to 4 weeks, then plateau, then recovery

Comparison: Poliomyelitis vs GBS

Feature	Poliomyelitis	GBS
Age	Any (mainly children)	Any age
Fever	Present at onset	Absent/mild
Symmetry	Asymmetric	Symmetric
Progression	24-48 hours	Days to weeks (up to 4 wks)
Sensory loss	None	Mild paresthesias
CSF	Pleocytosis	Albuminocytologic dissociation
Residual paralysis	Yes (>60 days)	Usually complete recovery
EMG/NCS	Anterior horn cell pattern	Demyelinating pattern
Respiratory	Bulbar form only	Up to 30%

Diagnosis

CSF: Classic "albuminocytologic dissociation" - elevated protein (>45 mg/dL) with normal cell count (<10 cells)
NCS/EMG: Reduced motor conduction velocity, prolonged F waves, conduction block
Anti-ganglioside antibodies (anti-GM1, anti-GQ1b)

Treatment

IVIg: 0.4 g/kg/day for 5 days - first line
Plasmapheresis: Equally effective
Corticosteroids: NOT recommended (no clinical benefit, may worsen)
Supportive care: ventilation if FVC <20 mL/kg or <25% predicted
Prevention of decubitus ulcers, DVT, infections
Physiotherapy

Prognosis

85-90% recover fully within weeks to months
~10% have residual deficits
~5% mortality (usually from autonomic complications or respiratory failure)

6. OTHER IMPORTANT AFP CAUSES

Transverse Myelitis

Bilateral symmetric weakness with a sensory level
Bladder and bowel dysfunction
MRI: T2 hyperintensity in spinal cord
Post-infectious or demyelinating

Traumatic Neuritis (Injection Neuritis)

Common in India after IM injection in gluteal region (sciatic nerve injury)
Unilateral footdrop, history of injection
Must be differentiated from polio - included in AFP surveillance

Enterovirus D68 (EV-D68) Associated AFP

Major outbreaks 2014, 2016, 2018 in North America
Typically follows acute respiratory illness
MRI: anterior horn cell involvement (acute flaccid myelitis pattern)
No effective antiviral; supportive treatment

Enterovirus A71 (EV-A71)

Associated with Hand, Foot and Mouth Disease (HFMD)
Can cause AFP, brainstem encephalitis, autonomic dysregulation
Severe disease in up to 30% hospitalized children

West Nile Virus AFP

Mosquito-borne (Culex sp.) flavivirus
Polio-like acute flaccid paralysis (anterior horn cell involvement)
Predilection for adults (mean age 56 years)
Asymmetric limb weakness, may spare sensory function

7. WHO CASE CLASSIFICATION OF AFP

After 60-day follow-up, AFP cases are classified as:

Confirmed Polio - Poliovirus isolated from stool AND residual paralysis at 60 days
Compatible - No stool specimen collected, residual paralysis or death
Discarded (non-polio AFP) - Adequate stool specimens, no poliovirus isolated; OR complete recovery without residual paralysis
Vaccine-Associated Paralytic Polio (VAPP) - Paralytic illness in OPV recipient or close contact; onset 4-30 days (recipient) or 4-75 days (contact) after OPV

8. Electrophysiology (NCS/EMG) in AFP

Condition	NCS Finding	EMG
Poliomyelitis / Anterior horn cell disease	Low/absent CMAP, normal SNAP, normal CV	Fibrillations, PSWs, reduced recruitment
GBS (AIDP)	Slowed CV, prolonged distal latency, conduction block	Reduced recruitment
Transverse myelitis	Normal peripherally	Abnormal only if anterior horn cells involved
Neuromuscular junction (myasthenia, botulism)	Decremental response on repetitive stimulation	-

9. Approach to a Child with AFP (MBBS Exam Approach)

History:

Onset and progression (hours to days = polio/GBS; weeks = GBS/myopathy)
Fever at onset (polio > GBS)
Preceding viral illness or diarrhea (GBS trigger)
Vaccination status (OPV history)
Recent IM injection (traumatic neuritis)
Animal bite (rabies)

Examination:

Pattern: Symmetric vs asymmetric
Tone: Hypotonic
Reflexes: Reduced/absent
Sensory examination
Cranial nerve involvement
Respiratory assessment (SpO2, vital capacity)

Investigations:

Stool for poliovirus (2 samples 24-48 hr apart)
CSF analysis
NCS/EMG
MRI spine/brain (if myelitis/ADEM suspected)
Anti-ganglioside antibodies (GBS)
Blood: CBC, electrolytes (periodic paralysis), LFTs, TFTs
Serology for arboviruses (West Nile, JE) if epidemiologically relevant

Sources: Bradley and Daroff's Neurology in Clinical Practice; Park's Textbook of Preventive and Social Medicine; Adams and Victor's Principles of Neurology; WHO AFP Surveillance Guidelines; Pediatric AFP teaching material (Nelson/Illustrated Textbook of Pediatrics equivalent content)

How to differntiate between causes of AFP

Finding Sources

Reading File

Finding Sources

Reading File

Finding Sources

I now have comprehensive data from all sources. Here is the detailed differentiation guide:

Differentiating Causes of Acute Flaccid Paralysis (AFP)

The framework for differentiation has 4 layers: History → Pattern of weakness → CSF → Electrophysiology (NCS/EMG) + imaging.

Layer 1 - Anatomical Localization First

The site of lesion determines the pattern of AFP:

Level	Examples	Key Clue
Anterior horn cell	Poliomyelitis, EV-D68, WNV	Asymmetric, no sensory loss, normal SNAP on NCS
Spinal cord (transverse)	Transverse myelitis, ADEM	Sensory level + bladder/bowel dysfunction
Nerve root / peripheral nerve	GBS, traumatic neuritis	Ascending/symmetric, albuminocytologic dissociation in CSF
Neuromuscular junction (NMJ)	Botulism, myasthenia gravis, tick paralysis	Cranial nerves first, decremental response on repetitive stimulation
Muscle	Periodic paralysis, myopathy	Proximal symmetric weakness, normal NCS, myopathic EMG

Layer 2 - Master Comparison Table

Feature	Poliomyelitis	GBS	Transverse Myelitis	Botulism	Tick Paralysis	Traumatic Neuritis
Age	Children <15 yr	Any	Any	Any	Children more	Any
Onset	Hours to 2 days	Days to 4 weeks	Hours to days	Hours to days	Days (after tick attach)	After IM injection
Direction	Variable (proximal > distal legs)	Ascending (legs → arms → trunk)	Below level of lesion	Descending (cranial first)	Ascending (legs → arms)	Single limb/nerve territory
Symmetry	Asymmetric	Symmetric	Bilateral	Symmetric	Symmetric	Unilateral
Fever at onset	Yes	Absent (post-infectious)	Variable	No	No	No
Preceding illness	GI/flu (5-35 days)	URTI/diarrhea (7-21 days prior)	Viral illness	Contaminated food	Tick bite (5-7 days)	IM injection
Sensory loss	None	Mild paresthesias	Sensory level present	None	None	Dermatomal (nerve territory)
Pain	Myalgia prominent	Limb pain, backache	Back pain	Absent	Minimal	Local
Deep tendon reflexes	Absent in affected limb	Globally absent	Absent early, hyperreflexic later	Absent	Absent	Absent in affected nerve
Cranial nerve involvement	Bulbar type only	Miller-Fisher variant (CN III, IV, VI)	No	Bilateral CN VI, VII first	Late, if tick not removed	No
Autonomic features	Mild	Prominent - BP swings, arrhythmias	Bladder/bowel	Dry mouth, dilated pupils, constipation	Minimal	No
Bladder/bowel	No (unless severe bulbar)	Occasionally	Yes - early prominent	Constipation (early)	No	No
Respiratory failure	Bulbar form	30% of GBS	Cervical level only	Common	If tick not removed	No
Residual paralysis	Yes, >60 days	Rare	Variable	Rare	No - resolves after tick removal	Variable

Layer 3 - CSF Analysis

Condition	Cells	Protein	Sugar	Special finding
Poliomyelitis	↑↑ (10-200; early PMN, then lymphocytes)	Normal / mildly ↑	Normal	Pleocytosis
GBS	Normal (<10 cells)	↑↑ (>45 mg/dL)	Normal	Albuminocytologic dissociation
Transverse myelitis	Lymphocytes ↑	↑	Normal	May have oligoclonal bands (if MS)
Botulism	Normal	Normal	Normal	CSF entirely normal
Tick paralysis	Normal	Normal	Normal	Normal
Traumatic neuritis	Normal	Normal or mild ↑	Normal	-
ADEM	Lymphocytes ↑	↑	Normal	MRI diagnostic

The single most exam-important point: GBS = high protein + normal cells (albuminocytologic dissociation). Polio = cells + protein both elevated.

Layer 4 - Electrophysiology (NCS / EMG)

Condition	Motor NCS (CMAP)	Sensory NCS (SNAP)	Conduction Velocity	EMG
Poliomyelitis (anterior horn cell)	Low amplitude CMAP	Normal	Normal	Fibrillations, PSWs, reduced recruitment, fasciculations
GBS - AIDP	Low amplitude ± conduction block	Low amplitude	Slowed	Reduced recruitment
GBS - AMAN	Low amplitude CMAP	Normal	Normal or mildly slow	Fibrillations
Transverse myelitis	Normal (peripheral nerve intact)	Normal	Normal	Normal (unless AHC involved)
Botulism	Normal CV; incremental response to high-frequency stimulation	Normal	Normal	Small CMAP, facilitation on rapid stimulation (Lambert-Eaton-like)
Tick paralysis	Reduced CMAP	Normal or mildly reduced	Normal	Normal or mild fibrillations
Myasthenia gravis	Normal	Normal	Normal	Decremental response at 3 Hz repetitive stimulation

Layer 5 - Specific Diagnostic Tests

Condition	Gold Standard Investigation
Poliomyelitis	Poliovirus isolation from stool (2 samples 24-48 hr apart, first 2 weeks)
GBS	CSF (albuminocytologic dissociation) + NCS (demyelinating pattern) + anti-ganglioside antibodies (anti-GM1, anti-GQ1b for Miller Fisher)
Transverse myelitis	MRI spine (T2 hyperintensity in cord, spanning ≥3 vertebral segments in NMOSD)
Botulism	Mouse bioassay for toxin in serum/stool/food; or culture of C. botulinum
Tick paralysis	Find and remove the tick - paralysis resolves within hours to days post-removal
Traumatic neuritis	History of injection + NCS showing axonal neuropathy in sciatic/peroneal distribution
Periodic paralysis	Serum K+ during attack; EMG during episode shows electrical silence
Myasthenia gravis	Anti-AChR antibodies; positive edrophonium (Tensilon) test; decremental response on RNS

Layer 6 - Clinical Scenarios / High-Yield Exam Clues

Scenario	Think of
Fever + asymmetric leg weakness in unvaccinated child	Poliomyelitis
Post-diarrheal (Campylobacter) symmetric ascending paralysis	GBS
Tingling + bilateral leg weakness + areflexia 2 weeks after URTI	GBS
Ophthalmoplegia + ataxia + areflexia (triad)	Miller-Fisher syndrome (GBS variant)
Diplopia + dysphagia + dry mouth after eating home-canned food	Botulism
Ascending paralysis in child, tick found in scalp	Tick paralysis
Back pain + bilateral leg weakness + urinary retention + sensory level at T10	Transverse myelitis
Unilateral footdrop after gluteal IM injection in infant	Traumatic (injection) neuritis
Episodic weakness after carbohydrate meal, low K+	Hypokalemic periodic paralysis
Animal bite + ascending paralysis + hydrophobia history	Paralytic rabies

The Poliomyelitis vs GBS Distinction (Most Tested)

This is the most commonly asked differentiation at MBBS exams:

Feature	Polio	GBS
Fever	Present at onset	Absent
Pattern	Asymmetric	Symmetric
Sensory	None	Mild paresthesias
Progression	Hours (24-48 hr max)	Days to weeks
CSF cells	Elevated (pleocytosis)	Normal
CSF protein	Normal/mildly up	Markedly elevated
NCS	Axonal (normal CV)	Demyelinating (slow CV)
Recovery	Permanent deficits common	Usually complete recovery
Treatment	Supportive only	IVIg / Plasmapheresis
Respiratory	Bulbar type only	Up to 30%

Sources: Bradley & Daroff's Neurology in Clinical Practice; Goldman-Cecil Medicine; Harrison's Principles of Internal Medicine 22e; Tintinalli's Emergency Medicine; Adams & Victor's Principles of Neurology; Park's Textbook of PSM

This is a shared conversation. Sign in to Orris to start your own chat.